Re: ZEN-3694 Single Agent Trial Status
in response to
by
posted on
Jul 14, 2017 02:24PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Does anyone have any reason why we have no news releases on the current trial ZEN 3694, I thought this trial would be very quick and we would have some new either way